Diagnosis

A peripheral T-cell lymphoma (PTCL) diagnosis often begins with a physical exam. Medical professionals usually look for enlarged lymph nodes in the neck, armpit and groin.

Other tests and procedures include blood tests, imaging tests and taking a sample of tissue for laboratory testing.

Biopsy

A biopsy is needed to diagnose peripheral T-cell lymphoma (PTCL). A biopsy is a procedure to remove a sample of tissue for testing in a lab. Your healthcare professional may take out a small sample or multiple samples of the affected tissue and bone marrow. The sample is tested in a lab to look for cancer cells.

Blood tests

Blood tests can sometimes show whether lymphoma cells are present. Blood tests may be used to test for viruses, including Epstein-Barr virus and human T-cell lymphotrophic virus (HTLV). Blood tests also measure levels of lactate dehydrogenase (LDH), which is often higher in people with lymphoma.

Imaging tests

An imaging test takes pictures inside the body. It can show the location and extent of PTCL. Tests may include a CT scan or a positron emission tomography (PET) scan.

Testing lymphoma cells in the lab

Lymphoma cells collected from a biopsy go to a lab for testing. In the lab, experts use specialized tests to look for specific things about the cells. When viewed under a microscope, the cancer cells look different from healthy cells. The healthcare team uses the test results to find out the type of peripheral T-cell lymphoma (PTCL) you have.

To decide whether the cells are PTCL cells, the experts in the lab look for:

  • Proteins on the surface of the cancer cells. Peripheral T-cell lymphoma (PTCL) cells can be identified by the presence of certain proteins on their surfaces. These proteins are known as markers.
  • Changes in the cancer cells' DNA. Cancer happens when cells get changes in their DNA. A cell's DNA holds the instructions that tell a cell what to do. Gene changes cause the cancer cells to multiply rapidly.

Treatment

Peripheral T-cell lymphoma (PTCL) is not a single condition. There are several subtypes under the PTCL umbrella. Healthcare professionals select treatments based on the PTCL subtype, the stage of the cancer and your overall health.

Since there are many subtypes, the type of first line treatment usually varies. PTCL treatment may include chemotherapy, radiation therapy, immunotherapy, targeted therapy, clinical trials and bone marrow transplant, also called bone marrow stem cell transplant.

Treatments may be more specialized if certain proteins such as CD30 are found on the T lymphocytes.

Chemotherapy

Chemotherapy treats cancer with strong medicines. There are many types of chemotherapy medicines. Most chemotherapy medicines are given through a vein. Some come in pill form.

Radiation therapy

Radiation therapy treats cancer with powerful energy beams. The energy can come from X-rays, protons or other sources. During radiation therapy, you lie on a table while a machine moves around you. The machine directs radiation to precise points in your body.

Targeted therapy

Targeted therapy for cancer is a treatment that uses medicines that attack specific chemicals in the cancer cells. By blocking these chemicals, targeted treatments can cause cancer cells to die.

Immunotherapy

Immunotherapy for cancer is a treatment with medicine that helps the body's immune system fight cancer cells. Typically, the immune system fights off diseases by attacking germs and other cells that shouldn't be in the body. Cancer cells survive by hiding from the immune system. Immunotherapy helps the immune system cells recognize and kill the cancer cells.

Bone marrow transplant

A bone marrow transplant, also called a bone marrow stem cell transplant, involves putting healthy bone marrow stem cells into the body. These cells replace cells hurt by chemotherapy and other treatments.

Autologous stem cell transplant and allogeneic stem cell transplant are procedures that can be used for T-cell lymphoma depending on the type of the disease.

Monitoring after treatment

It is common for peripheral T-cell lymphoma (PTCL) to come back after treatment. This is known as a relapse. The time it takes for a relapse to happen varies by subtype. After treatment, you have follow-up appointments to monitor for relapse. You may need repeat biopsies and imaging to confirm a relapse.

Prognosis

The cancer prognosis tells you how likely it is that the cancer can be treated successfully. Your healthcare team can get a general sense of your outlook based on your peripheral T-cell lymphoma (PTCL) subtype, its stage and other factors such as your overall health.

PTCL is considered fast growing. It can be hard to diagnose and may not be found until it has spread in your body.

Your healthcare team talks with you about treatment options that can give you the best chance for a desirable outcome.

People who are treated for PTCL also might have a higher chance of getting another cancer of a different type after treatment, sometimes many years later. Those cancers may include lung, brain, kidney, bladder, melanoma, Hodgkin lymphoma and acute nonlymphocytic leukemia.

Speak with your healthcare team about your prognosis if you want to know what to expect. Members of your healthcare team can explain what they consider when thinking about your prognosis.

Coping and support

People with serious illnesses often say they feel worried and stressed about the future. With time, these strategies may help you find comfort:

  • Ask questions about peripheral T-cell lymphoma (PTCL). Write down questions you have about your cancer. Ask these questions at your next appointment. Also ask your healthcare team for reliable sources where you can get more information.

    Knowing more about your cancer and your treatment options may make it easier to make decisions about your care.

  • Stay connected to friends and family. Keeping in touch with friends and family may give comfort during difficult times.

    Your friends and family may ask if there's anything they can do to help you, so think of tasks you might like help with. For example, you may ask for help caring for your home or pets if you are in the hospital.

    You may find comfort in the support of a caring group of your friends and family.

  • Find someone to talk with. Find a person who has experience helping people with serious illnesses. Ask your healthcare team to suggest a counselor, clergy member or medical social worker you can talk with. For support groups, contact the American Cancer Society or ask your healthcare team about local or online groups. Find support online through Mayo Clinic Connect, a community where you can connect with others for support, practical information and answers to everyday questions.

Preparing for your appointment

Make an appointment with a healthcare professional if you have any symptoms that worry you or are not going away.

If your healthcare professional thinks you might have peripheral T-cell lymphoma (PTCL), you may be referred to a doctor who specializes in diseases that affect blood cells, called a hematologist. If a cancer diagnosis is made, you also may be referred to a doctor who specializes in treating cancer, called an oncologist.

It is helpful to be prepared before you go to your appointment. Here is a starting point for getting ready.

What you can do

  • Be aware of anything you need to do ahead of time. At the time you make the appointment, be sure to ask whether there's anything you need to do in advance, such as prepare for lab work or other medical tests if needed.
  • Write down all the symptoms you have, including any that may not seem related to the reason for the appointment.
  • Make a list of all medicines, vitamins and supplements you're taking, how often you take them, and the doses for each.
  • Take along a family member or friend if possible. It can be hard to remember all the information you get during an appointment, especially if you feel overwhelmed. Someone who goes with you can take notes and may remember something that you missed or forgot.
  • Write down questions to ask your healthcare team.

For peripheral T-cell lymphoma (PTCL), some basic questions to ask include:

  • Do I have PTCL or a subtype of PTCL?
  • What is the stage of my PTCL?
  • Has the PTCL spread to other parts of my body?
  • Will I need more tests? If yes, please describe the tests and what they are for.
  • What are my treatment options? What is treatment like?
  • How much does each treatment prolong my life or increase my chances of a cure?
  • What are the potential side effects of each treatment?

Other questions could include:

  • How will each treatment affect my daily life?
  • Which treatment option do you believe is the best?
  • What would you recommend to a friend or family member in my situation?
  • How long does it take for the treatment to work?
  • What happens if the PTCL comes back after treatment? What are my options then?
  • What specialists will make up my care team?
  • What will determine follow-up visits?
  • Is there any printed information about PTCL you could give me? What websites do you recommend?

Don't hesitate to ask other questions.

What to expect from your doctor

Be prepared to answer questions, such as:

  • What are your symptoms?
  • When did your symptoms begin?
  • Do your symptoms happen all the time or do they come and go?
  • How bad are your symptoms?
  • What, if anything, seems to make your symptoms better?
  • What, if anything, seems to make your symptoms worse?
  • What worries you about your diagnosis or treatment?
April 10, 2026
  1. T-cell lymphomas. National Comprehensive Cancer Network. https://www.nccn.org. Accessed Dec. 30, 2025.
  2. Peripheral T-cell non-Hodgkin lymphoma treatment (PDQ) — Health professional version. National Cancer Institute. https://www.cancer.gov/types/lymphoma/hp/peripheral-t-cell-lymphoma-pdq. Accessed Dec. 30, 2025.
  3. Freedman A, et al. Clinical manifestations, pathologic features, and diagnosis of peripheral T-cell lymphoma, not otherwise specified. https://www.uptodate.com/contents/search. Accessed Dec. 30, 2025.
  4. Jacobson E, et al. Initial treatment of peripheral T cell lymphoma. https://www.uptodate.com/contents/search. Accessed Dec. 30, 2025.
  5. Jacobson E. Treatment of relapsed or refractory peripheral T cell lymphoma. https://www.uptodate.com/contents/search. Accessed Dec. 30, 2025.
  6. Elsevier Point of Care. Clinical Overview: Peripheral T-cell lymphoma. https://www.clinicalkey.com. Accessed Dec. 30, 2025.
  7. Hoffman R, et al. T-cell lymphoma. In: Hematology: Basic Principles and Practice. 8th ed. Elsevier; 2023. https://www.clinicalkey.com. Accessed Jan. 5, 2026.
  8. Jaffe ES, et al., eds. Hematopathology. 3rd ed. Elsevier; 2025. https://www.clinicalkey.com. Accessed Feb. 17, 2026.
  9. Goldman L, et al, eds. Non-Hodgkin lymphomas. In: Goldman-Cecil Medicine. 27th ed. Elsevier; 2024. https://www.clinicalkey.com. Accessed Feb. 17, 2026.
  10. Paulson CL. Allscripts EPSi. Mayo Clinic. July 15, 2025.